Archives

img-01

Liver Disease: A Growing Problem in Asia

This article was originally published on MedTech Intelligence. Driven largely by hepatitis in its various forms, liver disease has long been a fixture of life in China and Southeast Asia. Over the past three decades, public health programs in the region have... Read More

img-01

Foreign Manufacturer Registration in Japan

Under Japan’s Pharmaceuticals and Medical Devices Act (PMD Act), foreign companies that intend to manufacture drugs, quasi-drugs, active pharmaceutical ingredients (APIs) or medical devices overseas and import them into Japan must be registered with the Ministry of Health, Labor and Welfare (MHLW).... Read More

img-01

Japan Expands Share of Generic Drugs

Japan raised the share of generic drugs used in the country to 65.8 percent as of September 2017, putting it on course to reach its target of 80 percent by 2020. The switch to generics from brand-name drugs reduced medical costs by... Read More

img-01

Japan Pharmaceutical Market Set for Growth

Government reforms in recent years have laid the foundation for robust growth in Japan’s pharmaceutical sector. A report by pharma event company CPhI predicted that 2018 would be a “transformative” year for the pharmaceutical industry in Japan. The CPhI Global Pharma Index—a... Read More